EP Wealth Advisors LLC Buys Shares of 3,446 ICU Medical, Inc. $ICUI

Key Points

• EP Wealth Advisors LLC has acquired a new position in ICU Medical, purchasing 3,446 shares valued at approximately $479,000 in the first quarter.
• Several institutional investors significantly increased their stakes in ICU Medical, with The Manufacturers Life Insurance Company raising its holdings by 992.1%, now owning over 130,000 shares valued at $18.16 million.
• ICU Medical reported $2.10 earnings per share for the latest quarter, surpassing expectations, but noted an 8.0% decline in revenue compared to the same quarter last year.

EP Wealth Advisors LLC acquired a new position in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 3,446 shares of the medical instruments supplier's stock, valued at approximately $479,000.

Several other hedge funds have also recently bought and sold shares of the business. Xponance Inc. lifted its stake in ICU Medical by 5.3% in the 1st quarter. Xponance Inc. now owns 1,714 shares of the medical instruments supplier's stock worth $238,000 after acquiring an additional 86 shares in the last quarter. Blue Trust Inc. lifted its stake in ICU Medical by 23.0% in the 1st quarter. Blue Trust Inc. now owns 801 shares of the medical instruments supplier's stock worth $111,000 after acquiring an additional 150 shares in the last quarter. GAMMA Investing LLC lifted its stake in ICU Medical by 27.2% in the 1st quarter. GAMMA Investing LLC now owns 716 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 153 shares in the last quarter. Vise Technologies Inc. lifted its stake in ICU Medical by 7.1% in the 4th quarter. Vise Technologies Inc. now owns 2,649 shares of the medical instruments supplier's stock worth $411,000 after acquiring an additional 176 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in ICU Medical by 4.1% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,204 shares of the medical instruments supplier's stock worth $1,894,000 after acquiring an additional 478 shares in the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ICUI. Piper Sandler increased their price objective on ICU Medical from $145.00 to $153.00 and gave the stock an "overweight" rating in a research note on Wednesday. Raymond James Financial reduced their price objective on ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating for the company in a research note on Friday, August 8th. Finally, Wall Street Zen raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat, ICU Medical currently has an average rating of "Buy" and an average price target of $181.00.

ICU Medical Stock Down 3.4%

Shares of ICUI traded down $4.65 during midday trading on Friday, reaching $130.38. 240,362 shares of the stock were exchanged, compared to its average volume of 303,093. ICU Medical, Inc. has a 12-month low of $107.00 and a 12-month high of $196.26. The firm has a 50 day simple moving average of $126.23 and a 200-day simple moving average of $133.86. The company has a quick ratio of 1.17, a current ratio of 2.44 and a debt-to-equity ratio of 0.63. The company has a market cap of $3.22 billion, a price-to-earnings ratio of -85.78 and a beta of 0.86.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.44 by $0.66. ICU Medical had a positive return on equity of 7.24% and a negative net margin of 1.56%.The business had revenue of $543.57 million for the quarter, compared to the consensus estimate of $543.33 million. During the same period last year, the business earned $1.56 EPS. The firm's revenue was down 8.0% compared to the same quarter last year. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. Research analysts forecast that ICU Medical, Inc. will post 4.11 EPS for the current year.

Insider Buying and Selling

In related news, Director David C. Greenberg acquired 1,200 shares of the business's stock in a transaction that occurred on Wednesday, August 27th. The shares were acquired at an average cost of $126.42 per share, with a total value of $151,704.00. Following the purchase, the director owned 7,960 shares of the company's stock, valued at approximately $1,006,303.20. The trade was a 17.75% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Vivek Jain acquired 21,929 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The stock was bought at an average cost of $112.84 per share, for a total transaction of $2,474,468.36. Following the completion of the purchase, the chief executive officer directly owned 130,149 shares in the company, valued at $14,686,013.16. This represents a 20.26% increase in their position. The disclosure for this purchase can be found here. 1.50% of the stock is currently owned by company insiders.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.